Injectable HIV treatment unlikely to be arriving soon in the global south
Adherence counselling reverses viral rebound on dolutegravir in 95% of cases
What’s happened to services for key populations in Uganda following the Anti-Homosexuality Act?
Two modelling studies ask: will injectable PrEP ever be cost-effective at achievable prices?
People with HIV are not at greater risk for severe mpox unless they are immunosuppressed
Here is what transgender women across Asia want in PrEP
People with HIV remain at higher risk of dying from COVID-19 in the Omicron era
Integrase inhibitors raise the risk of diabetes regardless of weight gain
A perfect storm for stigma: gay and bisexual men’s experiences of mpox
